Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun medical limited - sodium chloride; potassium chloride; sodium lactate solution; calcium chloride dihydrate - solution for infusion - 6/6.24/0.40/0.27 %v/v - solutions affecting the electrolyte balance; electrolytes

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - clindamycin hydrochloride, quantity: 10 mg/ml - solution - excipient ingredients: dioctyl malate; purified water; ethanol - clindtech solution is indicated for the topical treatment of acne vulgaris, particularly forms in which comedones, papules and pastules predominate.

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun medical limited - sodium chloride potassium chloride sodium lactate solution calcium chloride dihydrate - solution for infusion - 500ml,1000 %v/v

Ireland - English - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - sodium chloride ; calcium chloride dihydrate ; potassium chloride ; sodium lactate solution 60% - solution for infusion - 6/0.27/0.4 grams - electrolytes

Ireland - English - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - sodium chloride ; calcium chloride dihydrate ; potassium chloride ; sodium lactate solution 60% - solution for infusion - grams - electrolytes

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag. - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate (as 50% solution) - solution for infusion - 0.600/0.040/0.027/0.312 grams/100 millilitres - electrolytes - cats, cattle, dogs, goats, horses, pigs, sheep - electrolytes

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium chloride, quantity: 6.43 g/l; potassium chloride, quantity: 1.19 g/l; magnesium chloride hexahydrate, quantity: 3.25 g/l; calcium chloride dihydrate, quantity: 0.176 g/l - solution - excipient ingredients: water for injections; hydrochloric acid - other conditions: the ph of the solution must be adjusted to 7.4 to 7. 8 with 10ml of sodium bicarbonate 8.4% w/v injection bp (not supplied) before use. indications: following ph adjustment with 10ml of sodium bicarbonate 8.4% w/v injection bp, cardioplegia "a" solution is used in combination with ischaemia and hypothermia to induce cardiac arrest during open heart surgery and to preserve the myocardium during asystole.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - calcium chloride dihydrate, quantity: 3.68 g/l; magnesium chloride hexahydrate, quantity: 2.44 g/l - solution, dialysis - excipient ingredients: hydrochloric acid; water for injections - phoxilium 1.2 mmol/l phosphate solution is used as a substitution solution and/or as a dialysis solution for crrt (continuous renal replacement therapy) in critically ill patients with acute kidney injury (aki) when ph and kalaemia have been restored to normal and when the patients need phosphate supplementation for loss of phosphate in the ultrafiltrate or to the dialysate during crrt.,phoxilium 1.2 mmol/l phosphate solution may also be used in case of drug poisoning or intoxications when the poisons are dialysable or pass through the membrane.,in these patient groups, phoxilium 1.2 mmol/l phosphate solution is indicated for use in patients with normal kalaemia and normal or hypophosphataemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - calcium chloride dihydrate, quantity: 5.145 g/l; magnesium chloride hexahydrate, quantity: 2.033 g/l; (s)-lactic acid, quantity: 5.4 g/l - solution, dialysis - excipient ingredients: water for injections - hemosol b0 solution is used in the treatment of acute kidney injury (aki) as a substitution solution in continuous haemofiltration and continuous haemodiafiltration and as a dialysis solution in continuous haemodialysis and continuous haemodiafiltration.,hemosol b0 solution may also be used in case of drug poisoning with dialysable or filterable substances.,in these patient groups, hemosol b0 is indicated for those with a tendency to hyperkalaemia; see precautions

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.